Utah Medical Products (UTMD) Retained Earnings (2010 - 2026)

Utah Medical Products' Retained Earnings history runs 17 years deep, the most recent figure standing at $130.3 million for Q1 2026.

• In Q1 2026, Retained Earnings rose 1.6% year-over-year to $130.3 million; the TTM figure through Mar 2026 stood at $130.3 million (up 1.6% YoY), while the FY2025 annual figure was $128.7 million, down 0.5% from the prior year.
• Retained Earnings was $130.3 million for Q1 2026 at Utah Medical Products, up from $128.7 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $139.0 million in Q1 2024 to a low of $117.8 million in Q1 2022.
• Historically, Retained Earnings has averaged $129.4 million across 5 years, with a median of $129.2 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Retained Earnings rose 10.89% in 2023, then declined 7.76% in 2025.
• A 5-year view of Retained Earnings shows it stood at $126.0 million in 2022, then grew by 9.79% to $138.3 million in 2023, then dropped by 6.53% to $129.3 million in 2024, then fell by 0.5% to $128.7 million in 2025, then advanced by 1.25% to $130.3 million in 2026.
• The last three Retained Earnings figures came in at $130.3 million (Q1 2026), $128.7 million (Q4 2025), and $128.0 million (Q3 2025), per Business Quant data.